Literature DB >> 9576629

Apoptosis, cancer and cancer therapy.

R J Bold1, P M Termuhlen, D J McConkey.   

Abstract

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis. Apoptosis is essential in the homeostasis of normal tissues of the body, especially those of the gastrointestinal tract, immune system and skin. There is increasing evidence that the processes of neoplastic transformation, progression and metastasis involve alterations in the normal apoptotic pathways. Furthermore, the majority of chemotherapeutic agents as well as radiation utilize the apoptotic pathway to induce cancer cell death. Resistance to standard chemotherapies also seems to be determined by alterations in the apoptotic pathways of cancer cells. Therefore, understanding the signals of apoptosis and the mechanism of apoptosis may allow the development of better chemo- or radiotherapeutic regimens for the treatment of cancer. Finally, components of the apoptotic pathway may represent potential therapeutic targets using gene therapy techniques.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9576629     DOI: 10.1016/s0960-7404(97)00015-7

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  56 in total

1.  Apoptotic DNA endonuclease (DNase-gamma) gene transfer induces cell death accompanying DNA fragmentation in human glioma cells.

Authors:  Ryuta Saito; Masaaki Mizuno; Toshihiro Kumabe; Takashi Yoshimoto; Sei-ichi Tanuma; Jun Yoshida
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

2.  Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status.

Authors:  Hideaki Ito; Takao Kanzawa; Toru Miyoshi; Satoshi Hirohata; Satoru Kyo; Arifumi Iwamaru; Hiroshi Aoki; Yasuko Kondo; Seiji Kondo
Journal:  Hum Gene Ther       Date:  2005-06       Impact factor: 5.695

3.  Apoptosis inducing effect of andrographolide on TD-47 human breast cancer cell line.

Authors:  Harjotaruno Sukardiman; Aty Widyawaruyanti; Noor Cholies Zaini
Journal:  Afr J Tradit Complement Altern Med       Date:  2007-02-16

Review 4.  Gene therapy for carcinoma of the breast.

Authors:  M A Stoff-Khalili; P Dall; D T Curiel
Journal:  Cancer Gene Ther       Date:  2006-01-06       Impact factor: 5.987

5.  [10]-Gingerol induces mitochondrial apoptosis through activation of MAPK pathway in HCT116 human colon cancer cells.

Authors:  Min Ju Ryu; Ha Sook Chung
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-08-23       Impact factor: 2.416

6.  Moringa oleifera fruit induce apoptosis via reactive oxygen species-dependent activation of mitogen-activated protein kinases in human melanoma A2058 cells.

Authors:  Tae Eun Guon; Ha Sook Chung
Journal:  Oncol Lett       Date:  2017-05-31       Impact factor: 2.967

7.  Radiation-induced gene signature predicts pathologic complete response to neoadjuvant chemotherapy in breast cancer patients.

Authors:  Daniel S Oh; Maggie C U Cheang; Cheng Fan; Charles M Perou
Journal:  Radiat Res       Date:  2014-02-14       Impact factor: 2.841

8.  Therapeutic efficacy of 188Re-liposome in a C26 murine colon carcinoma solid tumor model.

Authors:  Ya-Jen Chang; Chin-Wei Hsu; Chih-Hsien Chang; Keng-Li Lan; Gann Ting; Te-Wei Lee
Journal:  Invest New Drugs       Date:  2012-12-09       Impact factor: 3.850

9.  siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells.

Authors:  Dae Won Kim; Kyung-Ok Kim; Mike J Shin; Jung Hee Ha; Sung Wook Seo; Jay Yang; Francis Y Lee
Journal:  Mol Cancer       Date:  2009-05-15       Impact factor: 27.401

10.  Enabling Combinatorial siRNA Delivery against Apoptosis-Related Proteins with Linoleic Acid and α-Linoleic Acid Substituted Low Molecular Weight Polyethylenimines.

Authors:  Samarwadee Plianwong; Bindu Thapa; Remant Bahadur Kc; Cezary Kucharski; Theerasak Rojanarata; Hasan Uludağ
Journal:  Pharm Res       Date:  2020-02-03       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.